ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2586

Tendon and Ligament Involvement in Gout: A Dual Energy Computed Tomography Study

Nicola Dalbeth1, Ramanamma Kalluru2, Opetaia Aati3, Fiona M. McQueen4 and Anthony Doyle5, 1Medicine, University of Auckland, Auckland, New Zealand, 2Department of Rheumatology, Auckland District Health Board, Auckland, New Zealand, 3Department of Medicine, University of Auckland, Auckland, New Zealand, 4Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand, 5University of Auckland, Auckland, New Zealand

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Computed tomography (CT), gout and imaging techniques

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases III: Computed Tomography

Session Type: Abstract Submissions (ACR)

Background/Purpose: The involvement of bone and joints is widely recognized in gout.  However, soft tissue involvement is less well defined. Dual energy computed tomography (DECT) is a recently developed technology that enables detection of urate deposits.  The aim of this study was to examine the frequency and patterns of tendon and ligament involvement in patients with gout using DECT.

Methods: Ninety-two patients with tophaceous gout had a study visit including DECT scan of both feet.  Two readers scored the DECT scans for urate deposition at 20 tendon/ligament sites and 42 bone sites (total 1,840 tendon/ligament sites and 3,864 bone sites).  For affected tendons and ligaments, involvement was recorded as entheseal and/or non-entheseal (entheseal involvement was defined as urate deposition at the point of tendon/ligament insertion into bone). Inter-reader agreement for involvement at tendon/ligament sites was 88.0% and Cohen’s kappa was 0.58, and at bone sites was 94.7% and Cohen’s kappa was 0.77.  For a stringent analysis, urate deposition was considered present at each site only if reported by both readers.

Results: Urate deposition was observed in 199/1840 (10.8%) tendon/ligament sites and in 399/3864 (10.3%) bone sites (p=0.60). The Achilles tendon was the most frequently involved tendon/ligament site (39.1% all Achilles tendons), followed by the peroneal tendons (18.1%) (Figure).  Tibialis anterior and the extensor tendons were involved less frequently (7.6-10.3%), and the flexor tendons, plantar fascia and deltoid ligaments were involved infrequently (<5%) (p<0.0001 between sites). In those 72 Achilles tendons with urate deposition, 27 (38%) had only non-entheseal involvement, 29 (40%) had both entheseal and non-entheseal involvement, and 16 (22%) had only entheseal involvement. In contrast, entheseal involvement was less frequent at the other 127 affected tendon/ligament sites; 102 (80.3%) had only non-entheseal involvement, 25 (19.9%) had both entheseal and non-entheseal involvement, and 0 (0%) had only entheseal involvement (p<0.0001 compared with Achilles tendon site).

Conclusion: Urate deposition is observed in tendon and ligament sites in patients with gout using DECT. The Achilles tendon and enthesis are major sites of involvement in gout.  The patterns of urate deposition at certain tendon/ligament sites suggest that biomechanical strain or other local factors may contribute to formation of urate crystals.

Figure: Volume rendered DECT image demonstrating urate deposition in the Achilles and peroneal tendons.  Large adjacent tophi are present. Note normal tibialis anterior tendon.


Disclosure:

N. Dalbeth,
None;

R. Kalluru,
None;

O. Aati,
None;

F. M. McQueen,
None;

A. Doyle,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tendon-and-ligament-involvement-in-gout-a-dual-energy-computed-tomography-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology